Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Primary care providers can significantly improve practice performance as well as patient satisfaction by making one workaday adjustment: leaving some appointment slots open to accommodate walk-ins throughout the day.
Details are slim, but Ōura Health confirmed it submitted a draft registration with the Securities and Exchange Commission. The company received $900 million in new funding from investors in October.
The same day that Tennessee Gov. Bill Lee signed a bill that would force pharmacy benefit managers to divest from retail pharmacies, CVS Health filed a lawsuit to block its implementation.
Quorum Health said the move will allow it to save money through tax exemptions and provide its 11 hospitals with access to the 340B Drug Pricing Program. The health system is majority-owned by Goldentree Asset Management.
The acquisition of SPR Therapeutics will allow Medtronic to expand its portfolio of neuromodulator medical devices. The deal is expected to close in 2027.
Also worth a look: the ACR Data Science Institute’s AI Central, updated this week with detailed information on imaging AI products that have been cleared by the FDA.
A university in the Lone Star State is readying a master’s degree program that will prepare grad students to work as radiologic “techs” in all 50 states.
Three and a half weeks after abruptly closing shop due to unspecified technical difficulties, Hawaii Radiologic Associates is reopening its doors in stages.
Cloud giant Amazon Web Services is expanding its 1½ -year-old HealthLake data-management service in two imaging-specific directions. In the process it’s drawing vocal buy-in from healthcare providers as well as imaging vendors.
An imaging industry supplier best known for a widely adopted radiology reporting platform is partnering on radiological artificial intelligence with a company that pioneered GPUs and accelerated computing.
An established radiopharmaceutical can now be applied with the FDA’s blessing when symptoms of cognitive decline point to the second most common form of degenerative dementia (after only Alzheimer’s disease).
With its 108th scientific assembly and annual meeting a little more than two weeks away, the Radiological Society of North America is encouraging attendees to experience 2022’s big show virtually—even if they’ll be there in person.